Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T&R Biofab CoXKRX:246710 -0.68%57 Days Inventory is 51.65 as of Jun. 2026, which is 77% below its 10-year median of 227.45. GuruFocus rates XKRX:246710 with a GF Score™ of 57/100 and a GF Value™ of ₩19,469.96 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, T&R Biofab Co ranks better than 90.99% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). T&R Biofab Co's Average Total Inventories for the
three
months ended in Jun. 2026 was ₩3,592 Mil. T&R Biofab Co's Cost of Goods Sold for the
three
months ended in Jun. 2026 was ₩6,346 Mil.
Hence, T&R Biofab Co's Days Inventory for the
three
months ended in Jun. 2026 was 51.65.
The historical rank and industry rank for T&R Biofab Co's Days Inventory or its related term are showing as below:
XKRX:246710'
s Days Inventory Range Over the Past 10 Years
Min: 65.05 Med: 227.45 Max: 478.9
Current: 65.05
During the past 12 years, T&R Biofab Co's highest Days Inventory was 478.90. The lowest was 65.05. And the median was 227.45.
XKRX:246710's Days Inventory is ranked better than 90.99% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 177.785
vs XKRX:246710: 65.05
T&R Biofab Co's Days Inventory
declined
from Jun. 2025 (81.75) to Jun. 2026 (51.65).
Inventory Turnover measures how fast the company turns over its inventory within a year.
T&R Biofab Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 1.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
T&R Biofab Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.38.
T&R Biofab Co (XKRX:246710) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
T&R Biofab Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
T&R Biofab Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
T&R Biofab Co Days Inventory Related Terms
T&R Biofab Co Days Inventory Historical Data
* Premium members only.
The historical data trend for T&R Biofab Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:246710 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, T&R Biofab Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T&R Biofab Co Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, T&R Biofab Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where T&R Biofab Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T&R Biofab Co (XKRX:246710) has a Days Inventory of 51.65 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on T&R Biofab Co and its competitors. This is 77% below median its historical median of 227.45. Over the past decade, T&R Biofab Co's Days Inventory has ranged from 65.05 to 478.90. According to the industry distribution chart, T&R Biofab Co ranks #71 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is T&R Biofab Co's Days Inventory too high?
T&R Biofab Co's current Days Inventory of 51.65 is 77% below median its 10-year median of 227.45. Over the past 10 years, this metric has ranged from a low of 65.05 to a high of 478.90. The Medical Devices & Instruments industry median Days Inventory is 177.79. T&R Biofab Co's value of 51.65 is 70.9% below this industry median. Based on the distribution chart, T&R Biofab Co ranks #71 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, T&R Biofab Co has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does T&R Biofab Co's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, T&R Biofab Co ranks #71 out of 788 companies for Days Inventory. This places T&R Biofab Co in the top 9% of its industry — outperforming the majority of peers. The industry median Days Inventory is 177.79. T&R Biofab Co's value of 51.65 is 70.9% below this benchmark. Historically, T&R Biofab Co's own Days Inventory has ranged from 65.05 to 478.90 over the past decade. While the company's 10-year median is 227.45 vs. the industry median of 177.79, T&R Biofab Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 177.79, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. T&R Biofab Co's current Days Inventory of 51.65 is 70.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on T&R Biofab Co and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 177.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T&R Biofab Co's current Days Inventory is 51.65, which is 77% below median its own 10-year median of 227.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T&R Biofab Co stock overvalued right now?
Based on GuruFocus' analysis, T&R Biofab Co (XKRX:246710) is currently considered Possible Value Trap. The stock's GF Value™ is ₩19,469.96, compared to a current price of ₩2,200.00 — trading 88.7% below its estimated fair value. The current Days Inventory is 51.65, which is 77% below median its 10-year median of 227.45 and 70.9% below the Medical Devices & Instruments industry median of 177.79. T&R Biofab Co's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For T&R Biofab Co (XKRX:246710), the current Days Inventory is 51.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is T&R Biofab Co (XKRX:246710) Overvalued in 2026?
Based on GuruFocus' analysis, T&R Biofab Co stock appears to be undervalued.
The current stock price of ₩2,200.00 is trading 88.7% below its estimated GF Value™ of ₩19,469.96.
GuruFocus considers T&R Biofab Co to be Possible Value Trap.
Key valuation signals for XKRX:246710:
Days Inventory: 51.65 (77% below median its 10-year median of 227.45)
GF Value™: ₩19,469.96 vs. price of ₩2,200.00 (88.7% below fair value)
Industry Position: 70.9% below the Medical Devices & Instruments median (#71 of 788)
No single metric tells the full story. See the XKRX:246710 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.
57GF Score
Get the complete analysis for XKRX:246710
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:246710 has been successfully added to your 
